Search results
ASCO24: Enhertu aims to replace Herceptin in first-line metastatic breast cancer
Pharmaceutical Technology via Yahoo Finance· 2 weeks agoInterim safety and efficacy results of the Phase Ib/II Destiny-BREAST07 trial with Enhertu...
Seagen's (SGEN) Breast Cancer Study on Tuksya Combo Meets Goal
Zacks via Yahoo Finance· 10 months agoSeagen Inc. SGEN announced positive top-line results from its late-stage HER2CLIMB-02 study,...
What are the latest developments in breast cancer treatment? Central Mass. experts explain
Worcester Telegram & Gazette via Yahoo News· 8 months agoWORCESTER — October is Breast Cancer Awareness Month, and the rate of breast cancer incidence for...
Seagen's (SGEN) Tukysa Gets Accelerated FDA Nod for New Indication
Zacks via Yahoo Finance· 1 year agoThe FDA grants accelerated approval to Seagen's (SGEN) Tukysa in combination with trastuzumab for...
Jeanne Beker gets cancer treatment before winning Lifetime Achievement award
Yahoo Canada Style· 2 years agoJeanne Beker received cancer treatment before the Women Empowerment Awards. (Photo by Isaiah...
What Is Colorectal Cancer?
Verywell Health via Yahoo News· 1 year agoMedically reviewed by Jay N. Yepuri, MD Colorectal cancer is the uncontrolled growth of cells in the colon or rectum. It’s the fourth most common type of...
Breast cancer rates are rising. But more women are surviving too
KREX articles via Yahoo News· 8 months agoRapid drug development, personalized screening recommendations, targeted therapies and new...
Everything You Need to Know About HER2+ Breast Cancer Including How to Find Support Post-Diagnosis
SheKnows via Yahoo News· 2 years agoA breast cancer diagnosis is one of the scariest things someone could face. You’re worried, anxious,...
Roche (RHHBY) Cancer Drug Gets Breakthrough Therapy Designation
Zacks via Yahoo Finance· 4 weeks agoRoche's (RHHBY) inavolisib gets Breakthrough Therapy Designation in the United States for advanced...
Roche (RHHBY) Breast Cancer Drug Meets Primary Goal in Phase III
Zacks via Yahoo Finance· 6 months agoRoche's (RHHBY) phase III study evaluating inavolisib in combination with advanced hormone...
